Weekly docetaxel and mitoxantrone prior to prostatectomy in patients with high risk localized prostate cancer

被引：0
|
作者：
Beer, TM
Garzotto, M
Lowe, BA
Ellis, WJ
Lange, PH
Montalto, MA
Higano, C
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1662
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [21] Initial therapy with radical prostatectomy for high risk localized prostate cancer
    Montie, James E.
    JOURNAL OF UROLOGY, 2006, 176 (06): : S27 - S29
  • [22] Role of radical prostatectomy for high-risk localized prostate cancer
    Matsubara, A.
    Teishima, J.
    Yasumoto, H.
    Usui, T.
    Nakamoto, T.
    Maruyama, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 180 - 180
  • [23] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer
    Chi, Kim N.
    Chin, Joseph L.
    Winquist, Eric
    Klotz, Laurence
    Saad, Fred
    Gleave, Martin E.
    JOURNAL OF UROLOGY, 2008, 180 (02): : 565 - 570
  • [24] Weekly docetaxel in ormone refractory prostate cancer patients
    Lupo, G.
    Buemi, B.
    Marabello, G.
    Pettineo, G.
    Gnani, A.
    Caristi, N.
    Leone, A.
    Altavilla, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII153 - VII153
  • [25] Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer
    Garzotto, Mark
    Higano, Celestia S.
    O'Brien, Catherine
    Rademacher, Brooks L. S.
    Janeba, Nicole
    Fazli, Ladan
    Lange, Paul H.
    Lieberman, Stephen
    Beer, Tomasz M.
    CANCER, 2010, 116 (07) : 1699 - 1708
  • [26] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer - Comment
    Mohler, James L.
    JOURNAL OF UROLOGY, 2008, 180 (02): : 570 - 570
  • [27] Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer
    Beuzeboc, P.
    EUROPEAN UROLOGY, 2009, 55 (04) : 992 - 992
  • [28] Need for awareness and monitoring of ocular toxicities (OT) due to weekly docetaxel administration: Experience during a trial of neoadjuvant docetaxel (D) and mitoxantrone (M) for patients with high-risk prostate cancer (PC).
    Higano, CS
    Beer, TM
    Garzotto, M
    Ryan, CW
    Pitzel, M
    Works, CR
    Hall, SP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 401S - 401S
  • [29] Characterization of circulating tumor cells in patients with localized high risk prostate cancer, post-prostatectomy
    Anantharaman, Archana
    Friedlander, Terence W.
    Welty, Christopher J.
    Zejnullahu, Kreshnik
    Hough, Jeffrey
    Edwards, Matthew
    Jendrisak, Adam
    Lee, Jerry
    Greene, Stephanie
    Ontiveros, Priscilla
    Graf, Ryon
    Rodriguez, Angel
    Suraneni, Mahipal
    Wang, Yipeng
    Landers, Mark Andrew
    Cooperberg, Matthew R.
    Carroll, Peter
    Dittamore, Ryan Vance
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients
    Roder, Martin Andreas
    Berg, Kasper Drimer
    Christensen, Ib Jarle
    Gruschy, Lisa
    Brasso, Klaus
    Iversen, Peter
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 (01) : 19 - 25
12345